Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed May 9, 2025

Accession no.
0001628280-25-024355
Filed
May 9, 2025
Trade date
Apr 1-30, 2025
Filing delay
38 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions. Open-market purchases total $416.65. It was filed 38 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2025Common StockPPurchaseAcquired+4$4.24+$16.9632,396Direct
Apr 2, 2025Common StockPPurchaseAcquired+4$4.39+$17.5632,400Direct
Apr 3, 2025Common StockPPurchaseAcquired+4$4.21+$16.8432,404Direct
Apr 4, 2025Common StockPPurchaseAcquired+4$4.23+$16.9232,408Direct
Apr 7, 2025Common StockPPurchaseAcquired+4$4.19+$16.7632,412Direct
Apr 8, 2025Common StockPPurchaseAcquired+4$4.14+$16.5632,416Direct
Apr 9, 2025Common StockPPurchaseAcquired+4$4.09+$16.3632,420Direct
Apr 10, 2025Common StockPPurchaseAcquired+4$4.01+$16.0432,424Direct
Apr 11, 2025Common StockPPurchaseAcquired+4$4.02+$16.0832,428Direct
Apr 14, 2025Common StockPPurchaseAcquired+5$4.03+$20.1532,433Direct
Apr 15, 2025Common StockPPurchaseAcquired+5$4.14+$20.732,438Direct
Apr 16, 2025Common StockPPurchaseAcquired+5$4.23+$21.1532,443Direct
Apr 17, 2025Common StockPPurchaseAcquired+5$4.61+$23.0532,448Direct
Apr 21, 2025Common StockPPurchaseAcquired+5$4.79+$23.9532,453Direct
Apr 22, 2025Common StockPPurchaseAcquired+5$4.74+$23.732,458Direct
Apr 23, 2025Common StockPPurchaseAcquired+5$5.01+$25.0532,463Direct
Apr 24, 2025Common StockPPurchaseAcquired+5$5.12+$25.632,468Direct
Apr 25, 2025Common StockPPurchaseAcquired+5$4.94+$24.732,473Direct
Apr 28, 2025Common StockPPurchaseAcquired+4$4.91+$19.6432,477Direct
Apr 29, 2025Common StockPPurchaseAcquired+4$4.93+$19.7232,481Direct
Apr 30, 2025Common StockPPurchaseAcquired+4$4.79+$19.1632,485Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)